[1]
Swan MC, Furniss D, Cassell OC. Surgical management of metastatic inguinal lymphadenopathy. BMJ (Clinical research ed.). 2004 Nov 27:329(7477):1272-6
[PubMed PMID: 15564260]
[2]
Filippakis GM, Zografos G. Contraindications of sentinel lymph node biopsy: are there any really? World journal of surgical oncology. 2007 Jan 29:5():10
[PubMed PMID: 17261174]
[3]
Conzo G, Docimo G, Mauriello C, Gambardella C, Esposito D, Cavallo F, Tartaglia E, Napolitano S, Santini L. The current status of lymph node dissection in the treatment of papillary thyroid cancer. A literature review. La Clinica terapeutica. 2013:164(4):e343-6. doi: 10.7417/CT.2013.1599. Epub
[PubMed PMID: 24045534]
[5]
Suami H. Lymphosome concept: Anatomical study of the lymphatic system. Journal of surgical oncology. 2017 Jan:115(1):13-17. doi: 10.1002/jso.24332. Epub 2016 Jun 22
[PubMed PMID: 27334241]
[6]
Ruddle NH, Akirav EM. Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response. Journal of immunology (Baltimore, Md. : 1950). 2009 Aug 15:183(4):2205-12. doi: 10.4049/jimmunol.0804324. Epub
[PubMed PMID: 19661265]
[7]
Yin C, Mohanta S, Maffia P, Habenicht AJ. Editorial: Tertiary Lymphoid Organs (TLOs): Powerhouses of Disease Immunity. Frontiers in immunology. 2017:8():228. doi: 10.3389/fimmu.2017.00228. Epub 2017 Mar 6
[PubMed PMID: 28321222]
Level 3 (low-level) evidence
[8]
Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sautès-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L, Wargo JA. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020 Jan:577(7791):549-555. doi: 10.1038/s41586-019-1922-8. Epub 2020 Jan 15
[PubMed PMID: 31942075]
[9]
Vittet D. Lymphatic collecting vessel maturation and valve morphogenesis. Microvascular research. 2014 Nov:96():31-7. doi: 10.1016/j.mvr.2014.07.001. Epub 2014 Jul 12
[PubMed PMID: 25020266]
[10]
Moore JE Jr, Bertram CD. Lymphatic System Flows. Annual review of fluid mechanics. 2018 Jan:50():459-482. doi: 10.1146/annurev-fluid-122316-045259. Epub
[PubMed PMID: 29713107]
[11]
Padera TP, Meijer EF, Munn LL. The Lymphatic System in Disease Processes and Cancer Progression. Annual review of biomedical engineering. 2016 Jul 11:18():125-58. doi: 10.1146/annurev-bioeng-112315-031200. Epub 2016 Feb 5
[PubMed PMID: 26863922]
[12]
Datta K, Muders M, Zhang H, Tindall DJ. Mechanism of lymph node metastasis in prostate cancer. Future oncology (London, England). 2010 May:6(5):823-36. doi: 10.2217/fon.10.33. Epub
[PubMed PMID: 20465393]
[13]
Lee SW, Kawai M, Tashiro K, Bouras G, Kawashima S, Tanaka R, Nomura E, Uchiyama K. Laparoscopic distal gastrectomy with D2 lymphadenectomy followed by intracorporeal gastroduodenostomy for advanced gastric cancer: technical guide and tips. Translational gastroenterology and hepatology. 2017:2():84. doi: 10.21037/tgh.2017.10.02. Epub 2017 Oct 24
[PubMed PMID: 29167831]
[14]
Koifman L, Hampl D, Koifman N, Vides AJ, Ornellas AA. Radical open inguinal lymphadenectomy for penile carcinoma: surgical technique, early complications and late outcomes. The Journal of urology. 2013 Dec:190(6):2086-92. doi: 10.1016/j.juro.2013.06.016. Epub 2013 Jun 11
[PubMed PMID: 23770135]
[15]
Li J, Jia S, Zhang W, Qiu F, Zhang Y, Gu X, Xue J. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer. BMC surgery. 2015 Jun 30:15():79. doi: 10.1186/s12893-015-0067-4. Epub 2015 Jun 30
[PubMed PMID: 26123412]
Level 2 (mid-level) evidence
[16]
Beveridge TS, Allman BL, Johnson M, Power A, Sheinfeld J, Power NE. Retroperitoneal Lymph Node Dissection: Anatomical and Technical Considerations from a Cadaveric Study. The Journal of urology. 2016 Dec:196(6):1764-1771. doi: 10.1016/j.juro.2016.06.091. Epub 2016 Jul 5
[PubMed PMID: 27389330]
[17]
Mulita F, Parchas N, Germanos S, Papadoulas S, Maroulis I. Case Report of a Local Recurrence of Spindle Cell Embryonal Rhabdomyosarcoma. Medical archives (Sarajevo, Bosnia and Herzegovina). 2020 Jun:74(3):240-242. doi: 10.5455/medarh.2020.74.240-242. Epub
[PubMed PMID: 32801444]
Level 3 (low-level) evidence
[18]
Stewart DB, Dietz DW. Total mesorectal excision: what are we doing? Clinics in colon and rectal surgery. 2007 Aug:20(3):190-202. doi: 10.1055/s-2007-984863. Epub
[PubMed PMID: 20011200]
[19]
Young M, Pigazzi A. Total mesorectal excision: open, laparoscopic or robotic. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 2014:203():47-55. doi: 10.1007/978-3-319-08060-4_6. Epub
[PubMed PMID: 25102999]
[20]
Lee KY, Shin JK, Park YA, Yun SH, Huh JW, Cho YB, Kim HC, Lee WY. Transanal Endoscopic and Transabdominal Robotic Total Mesorectal Excision for Mid-to-Low Rectal Cancer: Comparison of Short-term Postoperative and Oncologic Outcomes by Using a Case-Matched Analysis. Annals of coloproctology. 2018 Feb:34(1):29-35. doi: 10.3393/ac.2018.34.1.29. Epub 2018 Feb 28
[PubMed PMID: 29535985]
Level 3 (low-level) evidence
[21]
Roy S, Shetty V, Sherigar V, Hegde P, Prasad R. Evaluation of Four Incisions Used For Radical Neck Dissection- A Comparative Study. Asian Pacific journal of cancer prevention : APJCP. 2019 Feb 26:20(2):575-580
[PubMed PMID: 30803224]
[22]
Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. The British journal of surgery. 1986 Jul:73(7):580-4
[PubMed PMID: 3730795]
[23]
Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight G, Winer EP. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer. 1998 Oct 1:83(7):1362-8
[PubMed PMID: 9762937]
Level 3 (low-level) evidence
[24]
Barchi LC, Charruf AZ, de Oliveira RJ, Jacob CE, Cecconello I, Zilberstein B. Management of postoperative complications of lymphadenectomy. Translational gastroenterology and hepatology. 2016:1():92. doi: 10.21037/tgh.2016.12.05. Epub 2016 Dec 27
[PubMed PMID: 28138657]
[25]
Franchi M, Ghezzi F, Riva C, Miglierina M, Buttarelli M, Bolis P. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. Journal of surgical oncology. 2001 Dec:78(4):232-7; discussion 237-40
[PubMed PMID: 11745815]
[26]
Abass MO, Gismalla MDA, Alsheikh AA, Elhassan MMA. Axillary Lymph Node Dissection for Breast Cancer: Efficacy and Complication in Developing Countries. Journal of global oncology. 2018 Oct:4():1-8. doi: 10.1200/JGO.18.00080. Epub
[PubMed PMID: 30281378]
[27]
Gupta S, Gupta N, Kadayaprath G, Neha S. Use of Sentinel Lymph Node Biopsy and Early Physiotherapy to Reduce Incidence of Lymphedema After Breast Cancer Surgery: an Institutional Experience. Indian journal of surgical oncology. 2020 Mar:11(1):15-18. doi: 10.1007/s13193-019-01030-4. Epub 2020 Jan 7
[PubMed PMID: 32205962]
[28]
Polistena A, Monacelli M, Lucchini R, Triola R, Conti C, Avenia S, Barillaro I, Sanguinetti A, Avenia N. Surgical morbidity of cervical lymphadenectomy for thyroid cancer: A retrospective cohort study over 25 years. International journal of surgery (London, England). 2015 Sep:21():128-34. doi: 10.1016/j.ijsu.2015.07.698. Epub 2015 Aug 5
[PubMed PMID: 26253851]
Level 2 (mid-level) evidence
[29]
Gervasoni JE Jr, Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. The Surgical clinics of North America. 2000 Dec:80(6):1631-73
[PubMed PMID: 11140865]
[30]
Maccio L, Barresi V, Domati F, Martorana E, Cesinaro AM, Migaldi M, Iachetta F, Ieni A, Bonetti LR. Clinical significance of pelvic lymph node status in prostate cancer: review of 1690 cases. Internal and emergency medicine. 2016 Apr:11(3):399-404. doi: 10.1007/s11739-015-1375-5. Epub 2016 Feb 13
[PubMed PMID: 26875178]
Level 3 (low-level) evidence
[31]
Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. The New England journal of medicine. 2017 Jun 8:376(23):2211-2222. doi: 10.1056/NEJMoa1613210. Epub
[PubMed PMID: 28591523]